Pharma, Biotech & Devices Retatrutide Phase 3: Half of Patients Lost 30% of Body Weight - Eli Lilly's Next GLP-1 Could Rival Bariatric Surgery 5 days ago #Retatrutide #Tirzepatize Read Article →